SCHEMBL24333377

SCHEMBL24333377

CCc1ccc(C)c(S(=O)(=O)NC(O)c2cc3c(F)cc(N4CCC4)cc3o2)c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.34
TP53 P04637 4/20 0.34
MAPT P10636 4/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
RRM1 P23921 1/20 0.33
RRM2B Q7LG56 1/20 0.33
ALDH1A1 P00352 4/20 0.32
IDH1 O75874 2/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
POLB P06746 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469637 0.83 POLB (0.37) LMNATP53MAPTALDH1A1POLB
SCHEMBL24333964 0.81 HTR6 (0.33) LMNATP53MAPTALDH1A1SMN1; SMN2
SCHEMBL24333639 0.80 TSHR (0.43) LMNATP53MAPTALDH1A1TSHR
SCHEMBL24333956 0.79
SCHEMBL24334394 0.79 PGAM1 (0.33) LMNAMAPTALDH1A1TSHRPOLB
SCHEMBL24333723 0.78 KMT2A (0.34) TSHRSMN1; SMN2POLBL3MBTL1HPGD
SCHEMBL24333402 0.77 ALDH1A1 (0.45) LMNATP53MAPTALDH1A1TSHR
SCHEMBL24333670 0.77 CCR8 (0.33) LMNATP53MAPTALDH1A1TSHR
SCHEMBL24334438 0.77 SLC22A12 (0.36) MAPTCHRM1ALDH1A1NPSR1KMT2A
SCHEMBL24333658 0.77 ALDH1A1 (0.35) MAPTALDH1A1SMN1; SMN2HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed